Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a PubMed publications note indicating automatic population of publications and updated the revision tag to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:03:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the banner about a lapse in government funding; no other study-related content appears to have changed.
    Difference
    0.3%
    Check dated 2025-11-17T18:26:26.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the study details appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T12:49:01.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T17:35:55.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software release.
    Difference
    0.0%
    Check dated 2025-09-28T11:13:02.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page version was updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:42:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.